OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality
Farid Saad, Monica Caliber, Gheorghe Doros, et al.
The Aging Male (2019) Vol. 23, Iss. 1, pp. 81-92
Closed Access | Times Cited: 65
Farid Saad, Monica Caliber, Gheorghe Doros, et al.
The Aging Male (2019) Vol. 23, Iss. 1, pp. 81-92
Closed Access | Times Cited: 65
Showing 1-25 of 65 citing articles:
The Role of Testosterone in the Elderly: What Do We Know?
Biagio Barone, Luigi Napolitano, Marco Abate, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3535-3535
Open Access | Times Cited: 69
Biagio Barone, Luigi Napolitano, Marco Abate, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3535-3535
Open Access | Times Cited: 69
Involvement of p38 MAPK in Leydig cell aging and age-related decline in testosterone
Dandan Luo, Xiangyu Qi, Xiaoqin Xu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 17
Dandan Luo, Xiangyu Qi, Xiaoqin Xu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 17
Cardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis
Giovanni Corona, Giulia Rastrelli, Clotilde Sparano, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 5, pp. 565-579
Closed Access | Times Cited: 5
Giovanni Corona, Giulia Rastrelli, Clotilde Sparano, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 5, pp. 565-579
Closed Access | Times Cited: 5
Factors Associated With Erectile Dysfunction in Men: A Cross-Sectional Study From Balochistan, Pakistan
Noman Sadiq, Jamshed Warsi
Cureus (2025)
Open Access
Noman Sadiq, Jamshed Warsi
Cureus (2025)
Open Access
Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men
Bruno Lunenfeld, George Mskhalaya, Michael Zitzmann, et al.
The Aging Male (2021) Vol. 24, Iss. 1, pp. 119-138
Open Access | Times Cited: 39
Bruno Lunenfeld, George Mskhalaya, Michael Zitzmann, et al.
The Aging Male (2021) Vol. 24, Iss. 1, pp. 119-138
Open Access | Times Cited: 39
Anabolic-Androgenic Steroid Use in Sports, Health, and Society
Shalender Bhasin, Disa L. Hatfield, Jay R. Hoffman, et al.
Medicine & Science in Sports & Exercise (2021) Vol. 53, Iss. 8, pp. 1778-1794
Open Access | Times Cited: 32
Shalender Bhasin, Disa L. Hatfield, Jay R. Hoffman, et al.
Medicine & Science in Sports & Exercise (2021) Vol. 53, Iss. 8, pp. 1778-1794
Open Access | Times Cited: 32
An overview of the history, current strategies, and potential future treatment approaches in erectile dysfunction: a comprehensive review
Mohammad Amin Langarizadeh, Amirhossein Salary, Marziye Ranjbar Tavakoli, et al.
Sexual Medicine Reviews (2023) Vol. 11, Iss. 3, pp. 253-267
Closed Access | Times Cited: 14
Mohammad Amin Langarizadeh, Amirhossein Salary, Marziye Ranjbar Tavakoli, et al.
Sexual Medicine Reviews (2023) Vol. 11, Iss. 3, pp. 253-267
Closed Access | Times Cited: 14
Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer
Louis Lenfant, Priscilla Léon, Géraldine Cancel‐Tassin, et al.
Urologic Oncology Seminars and Original Investigations (2020) Vol. 38, Iss. 8, pp. 661-670
Open Access | Times Cited: 36
Louis Lenfant, Priscilla Léon, Géraldine Cancel‐Tassin, et al.
Urologic Oncology Seminars and Original Investigations (2020) Vol. 38, Iss. 8, pp. 661-670
Open Access | Times Cited: 36
The Role of testosterone treatment in patients with metabolic disorders
Giovanni Corona, Giulia Rastrelli, Linda Vignozzi, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 9, pp. 1091-1103
Closed Access | Times Cited: 31
Giovanni Corona, Giulia Rastrelli, Linda Vignozzi, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 9, pp. 1091-1103
Closed Access | Times Cited: 31
Medicinal Use of Testosterone and Related Steroids Revisited
Jan Tauchen, Michal Jurášek, Lukáš Huml, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 1032-1032
Open Access | Times Cited: 29
Jan Tauchen, Michal Jurášek, Lukáš Huml, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 1032-1032
Open Access | Times Cited: 29
Testosterone treatment longer than 1 year shows more effects on functional hypogonadism and related metabolic, vascular, diabetic and obesity parameters (results of the 2-year clinical trial)
Kristina Groti Antonič, Blaž Antonič, Ivan Žuran, et al.
The Aging Male (2020) Vol. 23, Iss. 5, pp. 1442-1454
Open Access | Times Cited: 29
Kristina Groti Antonič, Blaž Antonič, Ivan Žuran, et al.
The Aging Male (2020) Vol. 23, Iss. 5, pp. 1442-1454
Open Access | Times Cited: 29
Endogenous Testosterone Levels and the Risk of Incident Cardiovascular Events in Elderly Men: The MrOS Prospective Study
Tinh‐Hai Collet, Susan K. Ewing, Kristine E. Ensrud, et al.
Journal of the Endocrine Society (2020) Vol. 4, Iss. 5
Open Access | Times Cited: 28
Tinh‐Hai Collet, Susan K. Ewing, Kristine E. Ensrud, et al.
Journal of the Endocrine Society (2020) Vol. 4, Iss. 5
Open Access | Times Cited: 28
Testosterone therapy for prevention and reversal of type 2 diabetes in men with low testosterone
Monica Caliber, Farid Saad
Current Opinion in Pharmacology (2021) Vol. 58, pp. 83-89
Closed Access | Times Cited: 26
Monica Caliber, Farid Saad
Current Opinion in Pharmacology (2021) Vol. 58, pp. 83-89
Closed Access | Times Cited: 26
Burden of Male Hypogonadism and Major Comorbidities, and the Clinical, Economic, and Humanistic Benefits of Testosterone Therapy: A Narrative Review
Sandy Yeo, Katsiaryna Holl, Nicolás Peñaherrera, et al.
ClinicoEconomics and Outcomes Research (2021) Vol. Volume 13, pp. 31-38
Open Access | Times Cited: 23
Sandy Yeo, Katsiaryna Holl, Nicolás Peñaherrera, et al.
ClinicoEconomics and Outcomes Research (2021) Vol. Volume 13, pp. 31-38
Open Access | Times Cited: 23
Role of Glucose-Lowering Medications in Erectile Dysfunction
Angelo Cignarelli, Valentina Annamaria Genchi, Rossella D’Oria, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2501-2501
Open Access | Times Cited: 21
Angelo Cignarelli, Valentina Annamaria Genchi, Rossella D’Oria, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2501-2501
Open Access | Times Cited: 21
Androgens and erectile dysfunction: from androgen deficiency to treatment
Yuan Wang, Rui Jiang
Sexual Medicine Reviews (2024) Vol. 12, Iss. 3, pp. 458-468
Open Access | Times Cited: 2
Yuan Wang, Rui Jiang
Sexual Medicine Reviews (2024) Vol. 12, Iss. 3, pp. 458-468
Open Access | Times Cited: 2
Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data
Mustafa Alwani, Aksam Yassin, Raidh Talib, et al.
Vascular Health and Risk Management (2021) Vol. Volume 17, pp. 497-508
Open Access | Times Cited: 18
Mustafa Alwani, Aksam Yassin, Raidh Talib, et al.
Vascular Health and Risk Management (2021) Vol. Volume 17, pp. 497-508
Open Access | Times Cited: 18
Erectile Dysfunction in Relation to Metabolic Disorders and the Concentration of Sex Hormones in Aging Men
Aleksandra Rył, Aleksandra Szylińska, Iwona Rotter
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 13, pp. 7576-7576
Open Access | Times Cited: 12
Aleksandra Rył, Aleksandra Szylińska, Iwona Rotter
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 13, pp. 7576-7576
Open Access | Times Cited: 12
The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts
Omer Faruk Kırlangıç, Didem Yilmaz‐Oral, Ecem Kaya‐Sezginer, et al.
Sexual Medicine (2020) Vol. 8, Iss. 2, pp. 132-155
Open Access | Times Cited: 19
Omer Faruk Kırlangıç, Didem Yilmaz‐Oral, Ecem Kaya‐Sezginer, et al.
Sexual Medicine (2020) Vol. 8, Iss. 2, pp. 132-155
Open Access | Times Cited: 19
The causes of adverse changes of testosterone levels in men
Michał Wrzosek, Jakub Woźniak, Dariusz Włodarek
Expert Review of Endocrinology & Metabolism (2020) Vol. 15, Iss. 5, pp. 355-362
Closed Access | Times Cited: 19
Michał Wrzosek, Jakub Woźniak, Dariusz Włodarek
Expert Review of Endocrinology & Metabolism (2020) Vol. 15, Iss. 5, pp. 355-362
Closed Access | Times Cited: 19
The association between sexual dysfunction and prostate cancer: a systematic review and meta-analysis
Diliyaer Dilixiati, Kaisaierjiang Kadier, Duolikun Laihaiti, et al.
The Journal of Sexual Medicine (2023) Vol. 20, Iss. 2, pp. 184-193
Closed Access | Times Cited: 6
Diliyaer Dilixiati, Kaisaierjiang Kadier, Duolikun Laihaiti, et al.
The Journal of Sexual Medicine (2023) Vol. 20, Iss. 2, pp. 184-193
Closed Access | Times Cited: 6
Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist?
Rossella Cannarella, Rosita A. Condorelli, Federica Dall’Oglio, et al.
International Journal of Endocrinology (2020) Vol. 2020, pp. 1-8
Open Access | Times Cited: 16
Rossella Cannarella, Rosita A. Condorelli, Federica Dall’Oglio, et al.
International Journal of Endocrinology (2020) Vol. 2020, pp. 1-8
Open Access | Times Cited: 16
The testosterone replacement therapy for prostate cancer patients: Time to take the leap?
Jennifer Le Guévelou, Guillaume Ploussard, Guilhem Roubaud, et al.
Andrology (2024)
Closed Access | Times Cited: 1
Jennifer Le Guévelou, Guillaume Ploussard, Guilhem Roubaud, et al.
Andrology (2024)
Closed Access | Times Cited: 1
Safety of testosterone therapy in men with prostate cancer
Abraham Morgentaler, Monica Caliber
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 11, pp. 1065-1076
Closed Access | Times Cited: 14
Abraham Morgentaler, Monica Caliber
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 11, pp. 1065-1076
Closed Access | Times Cited: 14
Late-onset hypogonadism: Clinical evidence, biological aspects and evolutionary considerations
Nikolai Jaschke, Andrew Wang, Lorenz C. Hofbauer, et al.
Ageing Research Reviews (2021) Vol. 67, pp. 101301-101301
Open Access | Times Cited: 12
Nikolai Jaschke, Andrew Wang, Lorenz C. Hofbauer, et al.
Ageing Research Reviews (2021) Vol. 67, pp. 101301-101301
Open Access | Times Cited: 12
